New pill aims to calm stomach paralysis nausea
Symptom relief
Ongoing
This Phase 2 trial tests whether CIN-102 (deudomperidone) can reduce nausea in adults with idiopathic gastroparesis, a condition where the stomach empties slowly. Over 400 participants will take either 10 mg, 15 mg, or a placebo twice daily for 12 weeks. Researchers will track sy…
Phase: PHASE2 • Sponsor: CinDome Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC